| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.912 | 0.004 | 0.912 | Analgesic | 0.847 0.005 CID_98840 0.846 0.005 CID_162171 | ||
| 0.82 | 0.005 | 0.82 | Antiobesity | 0.799 0.005 CID_98840 0.753 0.008 CID_162171 | ||
| 0.796 | 0.004 | 0.796 | HERG channel blocker | 0.611 0.008 CID_98840 0.532 0.013 CID_162171 | ||
| 0.752 | 0.005 | 0.752 | Potassium channel (Voltage-sensitive) blocker | 0.584 0.008 CID_98840 0.529 0.012 CID_162171 | ||
| 0.661 | 0.004 | 0.661 | Sigma receptor antagonist | 0.409 0.005 CID_98840 0.364 0.005 CID_162171 | ||
| 0.651 | 0.003 | 0.651 | Analgesic, opioid | 0.517 0.004 CID_98840 0.488 0.004 CID_162171 | ||
| 0.62 | 0.005 | 0.62 | Potassium channel blocker | 0.425 0.019 CID_98840 0.387 0.025 CID_162171 | ||
| 0.611 | 0.003 | 0.611 | Sigma 1 receptor antagonist | 0.168 0.005 CID_98840 0.164 0.005 CID_162171 | ||
| 0.593 | 0.007 | 0.593 | Anticonvulsant | 0.518 0.011 CID_98840 0.474 0.014 CID_162171 | ||
| 0.617 | 0.034 | 0.748 | Caspase 9 stimulant | 0.68 0.026 CID_98840 0.748 0.018 CID_162171 | CID_162171 | |
| 0.591 | 0.011 | 0.591 | Nootropic | 0.422 0.033 CID_98840 0.441 0.029 CID_162171 | ||
| 0.541 | 0.004 | 0.541 | Glutamate receptor antagonist | 0.393 0.005 CID_98840 0.38 0.005 CID_162171 | ||
| 0.55 | 0.02 | 0.55 | 5 Hydroxytryptamine release stimulant | 0.475 0.032 CID_98840 0.49 0.029 CID_162171 | ||
| 0.478 | 0.009 | 0.623 | Anesthetic general | 0.564 0.005 CID_98840 0.623 0.004 CID_162171 | CID_162171 | |
| 0.491 | 0.038 | 0.491 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.35 0.151 CID_98840 0.364 0.136 CID_162171 | ||
| 0.453 | 0.041 | 0.453 | GABA C receptor rho-3 antagonist | 0.299 0.117 CID_98840 0.263 0.144 CID_162171 | ||
| 0.383 | 0.025 | 0.383 | Sigma receptor agonist | 0.167 0.075 CID_98840 0.317 0.036 CID_162171 | ||
| 0.346 | 0.003 | 0.346 | Glycine transporter 1 inhibitor | 0.18 0.004 CID_98840 0.169 0.004 CID_162171 | ||
| 0.338 | 0.01 | 0.343 | Anesthetic local | 0.314 0.011 CID_98840 0.343 0.009 CID_162171 | CID_162171 | |
| 0.328 | 0.005 | 0.328 | NMDA receptor antagonist | 0.302 0.006 CID_98840 0.273 0.008 CID_162171 | ||
| 0.339 | 0.019 | 0.339 | Tyrosine 3 hydroxylase inhibitor | 0.283 0.042 CID_98840 0.264 0.055 CID_162171 | ||
| 0.324 | 0.004 | 0.324 | NMDA 2B receptor antagonist | 0.24 0.005 CID_98840 0.229 0.005 CID_162171 | ||
| 0.32 | 0.004 | 0.32 | Nav1.8 sodium channel blocker | 0.133 0.017 CID_98840 0.127 0.019 CID_162171 | ||
| 0.343 | 0.028 | 0.343 | 5 Hydroxytryptamine uptake stimulant | 0.305 0.042 CID_98840 0.279 0.057 CID_162171 | ||
| 0.316 | 0.004 | 0.316 | NMDA 2C receptor antagonist | 0.25 0.004 CID_98840 0.195 0.005 CID_162171 | ||
| 0.313 | 0.017 | 0.313 | Cholinergic | 0.171 0.062 CID_98840 0.192 0.05 CID_162171 | ||
| 0.345 | 0.054 | 0.405 | Spasmolytic | 0.405 0.039 CID_98840 0.393 0.041 CID_162171 | CID_98840 | |
| 0.343 | 0.055 | 0.376 | Calcium channel activator | 0.339 0.058 CID_98840 0.376 0.035 CID_162171 | CID_162171 | |
| 0.309 | 0.027 | 0.309 | Gastrin inhibitor | 0.273 0.055 CID_98840 0.294 0.037 CID_162171 | ||
| 0.298 | 0.016 | 0.526 | Alpha-N-acetylglucosaminidase inhibitor | 0.526 0.005 CID_98840 0.389 0.009 CID_162171 | CID_98840 | |
| 0.277 | 0.002 | 0.277 | Nociceptin (N/OFQ) receptor agonist | 0.162 0.003 CID_98840 0.149 0.003 CID_162171 | ||
| 0.279 | 0.005 | 0.279 | NMDA 2 receptor antagonist | 0.239 0.007 CID_98840 0.234 0.007 CID_162171 | ||
| 0.272 | 0.009 | 0.272 | 5 Hydroxytryptamine 3E antagonist | 0.179 0.109 CID_98840 0.183 0.098 CID_162171 | ||
| 0.259 | 0.011 | 0.259 | Nav1.1 sodium channel blocker | 0.202 0.019 CID_98840 0.174 0.025 CID_162171 | ||
| 0.242 | 0.006 | 0.242 | 5 Hydroxytryptamine 3A agonist | 0.108 0.067 CID_98840 0.116 0.059 CID_162171 | ||
| 0.24 | 0.005 | 0.24 | Antineoplastic alkaloid | 0.236 0.006 CID_98840 0.234 0.006 CID_162171 | ||
| 0.237 | 0.01 | 0.237 | Neuropeptide Y1 antagonist | 0.176 0.033 CID_98840 0.178 0.032 CID_162171 | ||
| 0.251 | 0.025 | 0.251 | Acetylcholine M1 receptor antagonist | 0.25 0.025 CID_98840 0.235 0.029 CID_162171 | ||
| 0.235 | 0.011 | 0.235 | Neuropeptide Y antagonist | 0.073 0.072 CID_98840 0.078 0.062 CID_162171 | ||
| 0.272 | 0.051 | 0.28 | Psychostimulant | 0.21 0.075 CID_98840 0.28 0.048 CID_162171 | CID_162171 | |
| 0.23 | 0.01 | 0.23 | Acetylcholine nicotinic antagonist | 0.165 0.017 CID_98840 0.173 0.016 CID_162171 | ||
| 0.272 | 0.054 | 0.374 | DNA synthesis inhibitor | 0.374 0.025 CID_98840 0.363 0.028 CID_162171 | CID_98840 | |
| 0.238 | 0.023 | 0.244 | Cholinergic antagonist | 0.244 0.022 CID_98840 0.222 0.027 CID_162171 | CID_98840 | |
| 0.219 | 0.005 | 0.219 | Opioid agonist | 0.168 0.006 CID_98840 0.131 0.009 CID_162171 | ||
| 0.218 | 0.004 | 0.218 | Nicotinic alpha4beta2 receptor antagonist | 0.128 0.014 CID_98840 0.155 0.007 CID_162171 | ||
| 0.236 | 0.023 | 0.241 | Acetylcholine antagonist | 0.241 0.022 CID_98840 0.219 0.026 CID_162171 | CID_98840 | |
| 0.274 | 0.061 | 0.274 | Superoxide dismutase inhibitor | 0.231 0.088 CID_98840 0.252 0.073 CID_162171 | ||
| 0.208 | 0.002 | 0.208 | NMDA receptor phencyclidine site antagonist | 0.102 0.002 CID_98840 0.138 0.002 CID_162171 | ||
| 0.206 | 0.004 | 0.206 | Glycine transporter inhibitor | 0.08 0.017 CID_98840 0.083 0.016 CID_162171 | ||
| 0.215 | 0.018 | 0.215 | GABA C receptor agonist | 0.161 0.03 CID_98840 0.141 0.038 CID_162171 | ||
| 0.195 | 0.004 | 0.195 | Nociceptin (N/OFQ) receptor antagonist | 0.082 0.007 CID_98840 0.077 0.008 CID_162171 | ||
| 0.245 | 0.062 | 0.245 | Neuropeptide Y2 antagonist | |||
| 0.196 | 0.015 | 0.196 | Opioid antagonist | 0.158 0.023 CID_98840 0.151 0.026 CID_162171 | ||
| 0.185 | 0.005 | 0.185 | NMDA receptor subunit 3B antagonist | 0.177 0.005 CID_98840 0.131 0.008 CID_162171 | ||
| 0.194 | 0.015 | 0.194 | Acetylcholine agonist | 0.12 0.037 CID_98840 0.147 0.027 CID_162171 | ||
| 0.258 | 0.079 | 0.306 | Aldehyde oxidase inhibitor | 0.249 0.083 CID_98840 0.306 0.065 CID_162171 | CID_162171 | |
| 0.262 | 0.085 | 0.262 | Insulysin inhibitor | |||
| 0.182 | 0.005 | 0.182 | NMDA 2A receptor antagonist | 0.094 0.015 CID_98840 0.099 0.013 CID_162171 | ||
| 0.186 | 0.009 | 0.186 | Neuronal nicotinic receptor antagonist | 0.12 0.017 CID_98840 0.125 0.016 CID_162171 | ||
| 0.25 | 0.074 | 0.25 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.198 | 0.025 | 0.219 | Acetylcholine muscarinic antagonist | 0.219 0.02 CID_98840 0.191 0.027 CID_162171 | CID_98840 | |
| 0.25 | 0.079 | 0.327 | Interleukin agonist | 0.296 0.05 CID_98840 0.327 0.036 CID_162171 | CID_162171 | |
| 0.177 | 0.011 | 0.177 | Acetylcholine nicotinic agonist | 0.089 0.046 CID_98840 0.086 0.049 CID_162171 | ||
| 0.241 | 0.077 | 0.241 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.274 | 0.111 | 0.331 | Vasodilator, peripheral | 0.256 0.123 CID_98840 0.331 0.082 CID_162171 | CID_162171 | |
| 0.176 | 0.014 | 0.176 | Phosphodiesterase 7B inhibitor | 0.112 0.044 CID_98840 0.117 0.04 CID_162171 | ||
| 0.158 | 0.005 | 0.158 | 5 Hydroxytryptamine 3 agonist | 0.076 0.03 CID_98840 0.076 0.03 CID_162171 | ||
| 0.166 | 0.016 | 0.166 | Prolactin inhibitor | 0.11 0.046 CID_98840 0.136 0.028 CID_162171 | ||
| 0.167 | 0.018 | 0.19 | Creatine kinase inhibitor | 0.19 0.012 CID_98840 0.171 0.016 CID_162171 | CID_98840 | |
| 0.163 | 0.015 | 0.163 | Opioid mu receptor antagonist | 0.12 0.025 CID_98840 0.118 0.025 CID_162171 | ||
| 0.159 | 0.012 | 0.159 | Acetylcholine release stimulant | 0.102 0.083 CID_98840 0.111 0.064 CID_162171 | ||
| 0.303 | 0.162 | 0.303 | 5 Hydroxytryptamine release inhibitor | 0.254 0.222 CID_98840 | ||
| 0.162 | 0.021 | 0.172 | Ca2+-transporting ATPase inhibitor | 0.172 0.012 CID_98840 0.167 0.015 CID_162171 | CID_98840 | |
| 0.145 | 0.005 | 0.145 | Substance P antagonist | 0.057 0.013 CID_98840 0.066 0.01 CID_162171 | ||
| 0.144 | 0.005 | 0.148 | NMDA receptor subunit 3A antagonist | 0.148 0.005 CID_98840 0.116 0.007 CID_162171 | CID_98840 | |
| 0.172 | 0.034 | 0.172 | Nav1.6 sodium channel blocker | 0.125 0.088 CID_98840 | ||
| 0.297 | 0.16 | 0.297 | Calcium channel L-type activator | 0.244 0.212 CID_162171 | ||
| 0.176 | 0.045 | 0.176 | GABA C receptor rho-2 antagonist | |||
| 0.132 | 0.004 | 0.132 | Nicotinic alpha3beta2 receptor antagonist | 0.099 0.008 CID_98840 0.13 0.004 CID_162171 | ||
| 0.171 | 0.044 | 0.171 | Acetylcholinesterase inhibitor | 0.108 0.092 CID_162171 | ||
| 0.212 | 0.092 | 0.212 | Antiamyloidogenic | 0.159 0.136 CID_98840 0.177 0.117 CID_162171 | ||
| 0.119 | 0.005 | 0.119 | Neurokinin 1 antagonist | 0.055 0.016 CID_98840 0.066 0.013 CID_162171 | ||
| 0.16 | 0.048 | 0.16 | Sodium channel (voltage-gated) blocker | |||
| 0.119 | 0.008 | 0.119 | Neurokinin antagonist | 0.056 0.028 CID_98840 0.061 0.024 CID_162171 | ||
| 0.12 | 0.011 | 0.12 | Acetylcholine M5 receptor agonist | 0.084 0.031 CID_98840 0.105 0.017 CID_162171 | ||
| 0.171 | 0.061 | 0.171 | Neurotensin receptor agonist | |||
| 0.132 | 0.022 | 0.132 | Histamine N-methyltransferase inhibitor | 0.081 0.065 CID_98840 0.092 0.054 CID_162171 | ||
| 0.144 | 0.036 | 0.144 | Butyrylcholinesterase inhibitor | |||
| 0.112 | 0.009 | 0.112 | Nicotinic receptor alpha3 subunit antagonist | 0.049 0.026 CID_98840 0.067 0.016 CID_162171 | ||
| 0.139 | 0.036 | 0.139 | GABA C receptor antagonist | 0.103 0.073 CID_98840 | ||
| 0.156 | 0.053 | 0.156 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.132 | 0.029 | 0.132 | Acetylcholine M3 receptor agonist | 0.128 0.031 CID_162171 | ||
| 0.11 | 0.008 | 0.11 | Nicotinic alpha7 receptor agonist | |||
| 0.112 | 0.01 | 0.112 | Nicotinic neuronal receptor agonist | |||
| 0.132 | 0.031 | 0.132 | GABA C receptor rho-1 antagonist | 0.089 0.08 CID_98840 | ||
| 0.155 | 0.054 | 0.189 | Adenylate cyclase stimulant | 0.173 0.032 CID_98840 0.189 0.02 CID_162171 | CID_162171 | |
| 0.144 | 0.045 | 0.144 | Beta amyloid protein antagonist | 0.1 0.09 CID_98840 0.111 0.076 CID_162171 | ||
| 0.108 | 0.009 | 0.11 | Phosphodiesterase VII inhibitor | 0.11 0.009 CID_98840 0.097 0.014 CID_162171 | CID_98840 | |
| 0.11 | 0.01 | 0.11 | Nicotinic receptor alpha7 subunit antagonist | 0.054 0.035 CID_98840 0.069 0.022 CID_162171 | ||
| 0.14 | 0.042 | 0.14 | Ferrochelatase inhibitor | |||
| 0.109 | 0.014 | 0.109 | CC chemokine 5 receptor agonist | 0.085 0.048 CID_98840 0.083 0.055 CID_162171 | ||
| 0.111 | 0.015 | 0.111 | Acetylcholine muscarinic agonist | 0.062 0.032 CID_98840 0.086 0.02 CID_162171 | ||
| 0.107 | 0.012 | 0.107 | Acetylcholine M1 receptor agonist | 0.045 0.028 CID_98840 0.08 0.016 CID_162171 | ||
| 0.171 | 0.079 | 0.171 | Succinate dehydrogenase inhibitor | 0.148 0.115 CID_98840 | ||
| 0.185 | 0.093 | 0.236 | Neurotrophic factor enhancer | 0.23 0.051 CID_98840 0.236 0.047 CID_162171 | CID_162171 | |
| 0.108 | 0.017 | 0.108 | Dopamine uptake inhibitor | 0.108 0.017 CID_98840 0.1 0.018 CID_162171 | ||
| 0.163 | 0.073 | 0.191 | Arachidonic acid antagonist | 0.191 0.042 CID_98840 0.188 0.045 CID_162171 | CID_98840 | |
| 0.236 | 0.148 | 0.275 | Vasodilator, coronary | 0.266 0.118 CID_98840 0.275 0.11 CID_162171 | CID_162171 | |
| 0.1 | 0.013 | 0.117 | MAP kinase kinase 7 inhibitor | 0.115 0.005 CID_98840 0.117 0.005 CID_162171 | CID_162171 | |
| 0.11 | 0.024 | 0.135 | Glycine receptor antagonist | 0.121 0.017 CID_98840 0.135 0.012 CID_162171 | CID_162171 | |
| 0.119 | 0.033 | 0.131 | Triose-phosphate isomerase inhibitor | 0.131 0.027 CID_98840 0.129 0.027 CID_162171 | CID_98840 | |
| 0.126 | 0.04 | 0.176 | UDP-glucose 4-epimerase inhibitor | 0.176 0.022 CID_98840 0.156 0.027 CID_162171 | CID_98840 | |
| 0.108 | 0.023 | 0.108 | Acetylcholine M4 receptor antagonist | 0.066 0.062 CID_98840 0.065 0.064 CID_162171 | ||
| 0.097 | 0.012 | 0.097 | Dopamine transporter inhibitor | 0.071 0.02 CID_98840 0.071 0.02 CID_162171 | ||
| 0.139 | 0.055 | 0.139 | Cathepsin H inhibitor | 0.12 0.075 CID_98840 0.105 0.099 CID_162171 | ||
| 0.155 | 0.072 | 0.155 | Cytidine deaminase inhibitor | 0.112 0.109 CID_98840 0.129 0.092 CID_162171 | ||
| 0.132 | 0.049 | 0.132 | Alpha 2b adrenoreceptor antagonist | |||
| 0.097 | 0.017 | 0.097 | Phospholipase D inhibitor | 0.093 0.02 CID_98840 0.094 0.018 CID_162171 | ||
| 0.142 | 0.064 | 0.142 | Sodium channel blocker | |||
| 0.114 | 0.037 | 0.114 | Glutamate (mGluR7) agonist | 0.111 0.04 CID_98840 0.11 0.042 CID_162171 | ||
| 0.105 | 0.028 | 0.105 | mTOR complex 2 inhibitor | 0.083 0.061 CID_98840 0.099 0.035 CID_162171 | ||
| 0.121 | 0.044 | 0.121 | DOPA decarboxylase inhibitor | 0.102 0.072 CID_98840 0.094 0.089 CID_162171 | ||
| 0.093 | 0.016 | 0.093 | Cathepsin E inhibitor | 0.069 0.03 CID_98840 0.07 0.029 CID_162171 | ||
| 0.134 | 0.06 | 0.134 | Nav1.3 sodium channel blocker | |||
| 0.174 | 0.101 | 0.227 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.206 0.067 CID_98840 0.227 0.054 CID_162171 | CID_162171 | |
| 0.094 | 0.022 | 0.094 | Secretase beta inhibitor | 0.072 0.047 CID_98840 0.079 0.037 CID_162171 | ||
| 0.09 | 0.019 | 0.098 | Protein kinase C beta inhibitor | 0.09 0.019 CID_98840 0.098 0.014 CID_162171 | CID_162171 | |
| 0.218 | 0.149 | 0.371 | Cholesterol antagonist | 0.317 0.081 CID_98840 0.371 0.057 CID_162171 | CID_162171 | |
| 0.076 | 0.008 | 0.08 | Phosphodiesterase 7A inhibitor | 0.08 0.006 CID_98840 0.071 0.011 CID_162171 | CID_98840 | |
| 0.078 | 0.01 | 0.078 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.14 | 0.073 | 0.157 | Pregnane X receptor agonist | 0.148 0.057 CID_98840 0.157 0.042 CID_162171 | CID_162171 | |
| 0.158 | 0.091 | 0.173 | Tumour necrosis factor antagonist | 0.173 0.074 CID_162171 | CID_162171 | |
| 0.184 | 0.119 | 0.193 | Nitric-oxide synthase stimulant | 0.193 0.101 CID_98840 0.18 0.128 CID_162171 | CID_98840 | |
| 0.101 | 0.035 | 0.101 | Porphobilinogen synthase inhibitor | |||
| 0.112 | 0.047 | 0.112 | Antihistaminic | |||
| 0.092 | 0.027 | 0.146 | Glycine receptor agonist | 0.137 0.009 CID_98840 0.146 0.007 CID_162171 | CID_162171 | |
| 0.102 | 0.038 | 0.102 | Bromodomain-containing protein 2 inhibitor | |||
| 0.087 | 0.023 | 0.112 | Acetylcholine M3 receptor antagonist | 0.112 0.015 CID_98840 0.091 0.021 CID_162171 | CID_98840 | |
| 0.08 | 0.017 | 0.08 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.084 | 0.021 | 0.084 | Alpha 2 adrenoreceptor agonist | 0.056 0.049 CID_162171 | ||
| 0.232 | 0.17 | 0.232 | Histamine release inhibitor | 0.219 0.182 CID_98840 0.218 0.182 CID_162171 | ||
| 0.129 | 0.069 | 0.152 | Toll-Like receptor 2 antagonist | 0.152 0.051 CID_98840 0.138 0.062 CID_162171 | CID_98840 | |
| 0.107 | 0.048 | 0.107 | Electrolyte absorption antagonist | |||
| 0.083 | 0.024 | 0.083 | Glutamate (mGluR7) antagonist | 0.064 0.055 CID_98840 | ||
| 0.104 | 0.046 | 0.104 | Histamine antagonist | |||
| 0.087 | 0.029 | 0.087 | Vanilloid 4 agonist | 0.074 0.054 CID_98840 0.076 0.05 CID_162171 | ||
| 0.071 | 0.013 | 0.071 | Glutamate (mGluR5) agonist | 0.042 0.04 CID_98840 | ||
| 0.211 | 0.154 | 0.31 | Caspase 3 stimulant | 0.259 0.105 CID_98840 0.31 0.074 CID_162171 | CID_162171 | |
| 0.077 | 0.02 | 0.077 | Potassium channel (Ca-activated) blocker | |||
| 0.113 | 0.056 | 0.113 | Aminopeptidase B inhibitor | |||
| 0.091 | 0.035 | 0.091 | Glutamate decarboxylase inhibitor | 0.071 0.053 CID_98840 0.07 0.055 CID_162171 | ||
| 0.083 | 0.028 | 0.083 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.082 | 0.027 | 0.113 | Carbamoyl phosphate synthetase inhibitor | 0.113 0.017 CID_98840 0.101 0.02 CID_162171 | CID_98840 | |
| 0.061 | 0.006 | 0.061 | Calcitonin gene-related peptide antagonist | |||
| 0.089 | 0.035 | 0.089 | Aminopeptidase I inhibitor | 0.075 0.047 CID_98840 0.079 0.043 CID_162171 | ||
| 0.079 | 0.025 | 0.079 | Acetylcholine M5 receptor antagonist | 0.059 0.044 CID_98840 0.055 0.049 CID_162171 | ||
| 0.078 | 0.024 | 0.082 | Cyclin-dependent kinase 6 inhibitor | 0.082 0.02 CID_98840 0.075 0.026 CID_162171 | CID_98840 | |
| 0.074 | 0.02 | 0.074 | Phosphodiesterase 1A inhibitor | |||
| 0.101 | 0.047 | 0.101 | Alpha 2 adrenoreceptor antagonist | |||
| 0.073 | 0.02 | 0.114 | Sphingosine kinase 2 inhibitor | 0.114 0.005 CID_98840 0.105 0.007 CID_162171 | CID_98840 | |
| 0.07 | 0.017 | 0.07 | Glutamate (mGluR group I) agonist | |||
| 0.153 | 0.1 | 0.224 | Phospholipase C inhibitor | 0.208 0.039 CID_98840 0.224 0.032 CID_162171 | CID_162171 | |
| 0.127 | 0.075 | 0.127 | Nav1.2 sodium channel blocker | |||
| 0.074 | 0.022 | 0.074 | Calcium channel P-type blocker | 0.071 0.025 CID_98840 0.071 0.026 CID_162171 | ||
| 0.071 | 0.021 | 0.118 | Glucosylceramidase inhibitor | 0.118 0.005 CID_98840 0.108 0.007 CID_162171 | CID_98840 | |
| 0.061 | 0.011 | 0.061 | Dopamine D5 agonist | 0.048 0.019 CID_98840 0.042 0.025 CID_162171 | ||
| 0.181 | 0.131 | 0.199 | RNA-directed DNA polymerase inhibitor | 0.199 0.101 CID_98840 0.196 0.106 CID_162171 | CID_98840 | |
| 0.081 | 0.032 | 0.081 | Potassium channel (Tandem pore domain) blocker | |||
| 0.076 | 0.03 | 0.098 | Aromatase inhibitor | 0.076 0.03 CID_98840 0.098 0.022 CID_162171 | CID_162171 | |
| 0.065 | 0.019 | 0.065 | Nicotinic receptor alpha4 subunit antagonist | |||
| 0.066 | 0.02 | 0.066 | Histamine H3 receptor antagonist | |||
| 0.104 | 0.058 | 0.146 | Anabolic | 0.139 0.025 CID_98840 0.146 0.02 CID_162171 | CID_162171 | |
| 0.095 | 0.049 | 0.121 | NADH dehydrogenase inhibitor | 0.121 0.028 CID_98840 0.11 0.035 CID_162171 | CID_98840 | |
| 0.057 | 0.011 | 0.057 | GABA uptake inhibitor | 0.037 0.032 CID_162171 | ||
| 0.077 | 0.032 | 0.077 | Acetylcholine M2 receptor antagonist | 0.07 0.037 CID_98840 0.06 0.045 CID_162171 | ||
| 0.126 | 0.082 | 0.126 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.125 | 0.081 | 0.125 | Toll-Like receptor 9 antagonist | |||
| 0.133 | 0.089 | 0.133 | Peroxidase inhibitor | 0.111 0.11 CID_98840 | ||
| 0.056 | 0.013 | 0.056 | Alpha 1d adrenoreceptor agonist | |||
| 0.105 | 0.061 | 0.105 | Alpha 2c adrenoreceptor antagonist | |||
| 0.074 | 0.032 | 0.077 | Glutamate (mGluR6) antagonist | 0.077 0.028 CID_98840 0.072 0.036 CID_162171 | CID_98840 | |
| 0.057 | 0.014 | 0.057 | Guanylate cyclase inhibitor | 0.057 0.015 CID_98840 0.051 0.02 CID_162171 | ||
| 0.091 | 0.05 | 0.091 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.077 | 0.036 | 0.077 | Nav1.7 sodium channel blocker | |||
| 0.094 | 0.053 | 0.094 | Glutamate release inhibitor | |||
| 0.059 | 0.018 | 0.063 | Cholesterol esterase inhibitor | 0.063 0.015 CID_98840 0.061 0.017 CID_162171 | CID_98840 | |
| 0.071 | 0.031 | 0.071 | Collagenase 3 inhibitor | 0.056 0.048 CID_98840 | ||
| 0.136 | 0.095 | 0.146 | Cyclin-dependent kinase 8 inhibitor | 0.141 0.089 CID_98840 0.146 0.084 CID_162171 | CID_162171 | |
| 0.102 | 0.063 | 0.128 | Adenylate kinase inhibitor | 0.128 0.038 CID_98840 0.117 0.046 CID_162171 | CID_98840 | |
| 0.103 | 0.067 | 0.103 | Falcipain 3 inhibitor | |||
| 0.045 | 0.009 | 0.045 | Tryptophan 5 hydroxylase inhibitor | 0.041 0.014 CID_98840 0.043 0.011 CID_162171 | ||
| 0.078 | 0.042 | 0.078 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.071 0.057 CID_98840 0.068 0.065 CID_162171 | ||
| 0.064 | 0.029 | 0.064 | Bromodomain-containing protein 4 inhibitor | |||
| 0.112 | 0.076 | 0.112 | Transcription factor STAT6 inhibitor | 0.108 0.086 CID_98840 | ||
| 0.061 | 0.026 | 0.089 | Alpha-mannosidase inhibitor | 0.089 0.008 CID_98840 0.089 0.008 CID_162171 | CID_162171 | |
| 0.06 | 0.025 | 0.06 | Prolyl endopeptidase inhibitor | |||
| 0.076 | 0.041 | 0.076 | Alpha adrenoreceptor agonist | |||
| 0.059 | 0.027 | 0.059 | Aconitate hydratase inhibitor | 0.047 0.044 CID_98840 | ||
| 0.067 | 0.034 | 0.067 | Phosphodiesterase 1C inhibitor | |||
| 0.107 | 0.075 | 0.107 | CDK3/cyclin E inhibitor | |||
| 0.041 | 0.009 | 0.041 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.041 | 0.009 | 0.041 | Vasopressin 1B antagonist | |||
| 0.059 | 0.028 | 0.059 | Histamine agonist | |||
| 0.066 | 0.035 | 0.066 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.044 | 0.013 | 0.044 | Acetylcholine M4 receptor agonist | 0.032 0.02 CID_162171 | ||
| 0.048 | 0.017 | 0.048 | Nicotinic receptor beta4 subunit antagonist | 0.034 0.03 CID_162171 | ||
| 0.067 | 0.037 | 0.067 | Cannabinoid CB1 receptor antagonist | |||
| 0.069 | 0.039 | 0.069 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.073 | 0.043 | 0.076 | Phenylalanine 4-hydroxylase inhibitor | 0.076 0.041 CID_98840 0.064 0.052 CID_162171 | CID_98840 | |
| 0.057 | 0.029 | 0.057 | Dipeptidyl peptidase inhibitor | |||
| 0.062 | 0.035 | 0.105 | Sphingosine kinase inhibitor | 0.105 0.006 CID_98840 0.092 0.01 CID_162171 | CID_98840 | |
| 0.058 | 0.031 | 0.06 | Acetylcholine M2 receptor agonist | 0.05 0.043 CID_98840 0.06 0.029 CID_162171 | CID_162171 | |
| 0.058 | 0.03 | 0.058 | Immunoglobulin Fc receptor antagonist | |||
| 0.049 | 0.022 | 0.049 | Dipeptidyl peptidase IV inhibitor | |||
| 0.043 | 0.017 | 0.043 | Delayed rectifier potassium channel blocker | 0.035 0.032 CID_98840 0.035 0.03 CID_162171 | ||
| 0.077 | 0.051 | 0.077 | Alpha 2a adrenoreceptor antagonist | |||
| 0.038 | 0.012 | 0.038 | Bradykinin B1 receptor antagonist | |||
| 0.036 | 0.01 | 0.036 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.101 | 0.076 | 0.106 | Cystathionine beta-synthase inhibitor | 0.106 0.07 CID_98840 0.093 0.086 CID_162171 | CID_98840 | |
| 0.059 | 0.034 | 0.059 | Pregnane X receptor antagonist | 0.059 0.033 CID_98840 0.057 0.038 CID_162171 | ||
| 0.071 | 0.047 | 0.111 | Phosphofructokinase-1 inhibitor | 0.111 0.028 CID_98840 0.097 0.033 CID_162171 | CID_98840 | |
| 0.043 | 0.02 | 0.043 | 5 Hydroxytryptamine 2B agonist | |||
| 0.045 | 0.022 | 0.045 | Heme oxygenase inhibitor | |||
| 0.078 | 0.055 | 0.078 | Metalloproteinase-2 inhibitor | 0.07 0.066 CID_98840 | ||
| 0.089 | 0.066 | 0.089 | HIV-1 integrase (Overall Integration) inhibitor | 0.084 0.073 CID_162171 | ||
| 0.132 | 0.11 | 0.132 | Heat shock protein 70 antagonist | 0.129 0.126 CID_98840 | ||
| 0.086 | 0.065 | 0.086 | Phosphodiesterase I inhibitor | |||
| 0.052 | 0.031 | 0.052 | Potassium channel (Inward rectifier) blocker | 0.045 0.041 CID_98840 | ||
| 0.042 | 0.021 | 0.048 | Arginase inhibitor | 0.048 0.016 CID_98840 0.043 0.02 CID_162171 | CID_98840 | |
| 0.12 | 0.1 | 0.12 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.059 | 0.04 | 0.059 | Ryanodine receptor antagonist | 0.056 0.05 CID_98840 0.056 0.05 CID_162171 | ||
| 0.049 | 0.03 | 0.049 | Opioid mu receptor agonist | 0.041 0.039 CID_98840 0.043 0.037 CID_162171 | ||
| 0.13 | 0.111 | 0.182 | Interferon gamma antagonist | 0.178 0.051 CID_98840 0.182 0.049 CID_162171 | CID_162171 | |
| 0.116 | 0.098 | 0.116 | Vanilloid 1 agonist | 0.113 0.105 CID_98840 0.116 0.098 CID_162171 | ||
| 0.049 | 0.031 | 0.049 | Cytokine production stimulant | |||
| 0.043 | 0.025 | 0.043 | Kainate receptor agonist | 0.042 0.026 CID_98840 0.041 0.028 CID_162171 | ||
| 0.113 | 0.096 | 0.113 | Toll-Like receptor antagonist | |||
| 0.06 | 0.043 | 0.06 | Cannabinoid CB1 receptor agonist | |||
| 0.07 | 0.054 | 0.07 | Orexin receptor 1 antagonist | |||
| 0.084 | 0.068 | 0.084 | Alpha adrenoreceptor antagonist | |||
| 0.087 | 0.07 | 0.096 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.096 0.058 CID_98840 0.085 0.073 CID_162171 | CID_98840 | |
| 0.05 | 0.034 | 0.05 | Squalene epoxidase inhibitor | 0.049 0.037 CID_162171 | ||
| 0.067 | 0.051 | 0.067 | Exportin-1 inhibitor | |||
| 0.044 | 0.028 | 0.044 | Nerve growth factor antagonist | |||
| 0.049 | 0.033 | 0.049 | Histamine H4 receptor antagonist | |||
| 0.055 | 0.039 | 0.156 | Alcohol oxidase inhibitor | 0.131 0.012 CID_98840 0.156 0.009 CID_162171 | CID_162171 | |
| 0.031 | 0.016 | 0.037 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.025 0.022 CID_98840 0.037 0.012 CID_162171 | CID_162171 | |
| 0.046 | 0.031 | 0.075 | Mannosidase inhibitor | 0.075 0.01 CID_98840 0.075 0.01 CID_162171 | CID_162171 | |
| 0.07 | 0.055 | 0.07 | Metalloproteinase-9 inhibitor | |||
| 0.055 | 0.041 | 0.077 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.077 0.022 CID_98840 0.069 0.027 CID_162171 | CID_98840 | |
| 0.046 | 0.033 | 0.061 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.048 0.031 CID_98840 0.061 0.022 CID_162171 | CID_162171 | |
| 0.063 | 0.05 | 0.063 | Dopamine agonist | |||
| 0.067 | 0.054 | 0.067 | Cannabinoid receptor antagonist | |||
| 0.13 | 0.118 | 0.158 | CF transmembrane conductance regulator agonist | 0.158 0.063 CID_98840 0.14 0.095 CID_162171 | CID_98840 | |
| 0.043 | 0.031 | 0.043 | Histamine H1 receptor agonist | |||
| 0.055 | 0.043 | 0.057 | Fatty acid synthase inhibitor | 0.057 0.039 CID_98840 | CID_98840 | |
| 0.02 | 0.008 | 0.02 | CXC chemokine 5 receptor antagonist | |||
| 0.054 | 0.042 | 0.054 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.041 | 0.029 | 0.075 | Sphingosine kinase 1 inhibitor | 0.075 0.005 CID_98840 0.063 0.008 CID_162171 | CID_98840 | |
| 0.08 | 0.068 | 0.085 | Estrogen-related receptor beta agonist | 0.082 0.061 CID_98840 0.085 0.053 CID_162171 | CID_162171 | |
| 0.036 | 0.024 | 0.054 | Ceramide glucosyltransferase inhibitor | 0.051 0.006 CID_98840 0.054 0.005 CID_162171 | CID_162171 | |
| 0.046 | 0.036 | 0.059 | Glucose-6-phosphate isomerase inhibitor | 0.059 0.019 CID_98840 0.055 0.023 CID_162171 | CID_98840 | |
| 0.022 | 0.012 | 0.022 | Imidazoline I1 receptor antagonist | |||
| 0.02 | 0.01 | 0.02 | Alpha 2c adrenoreceptor agonist | |||
| 0.057 | 0.047 | 0.057 | Phosphodiesterase 1B inhibitor | |||
| 0.044 | 0.034 | 0.067 | Adenylate cyclase 1 inhibitor | 0.052 0.024 CID_98840 0.067 0.014 CID_162171 | CID_162171 | |
| 0.136 | 0.127 | 0.136 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.031 | 0.021 | 0.031 | Epoxide hydrolase 1 inhibitor | |||
| 0.035 | 0.026 | 0.035 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.032 | 0.023 | 0.032 | Dipeptidyl peptidase II inhibitor | |||
| 0.04 | 0.032 | 0.04 | Oxytocin agonist | |||
| 0.063 | 0.055 | 0.063 | Alpha 1a adrenoreceptor antagonist | |||
| 0.054 | 0.047 | 0.066 | Biliverdin reductase inhibitor | 0.066 0.035 CID_98840 0.057 0.044 CID_162171 | CID_98840 | |
| 0.052 | 0.045 | 0.052 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.034 | 0.027 | 0.034 | Growth factor receptor-bound protein 2 antagonist | |||
| 0.027 | 0.021 | 0.027 | LFA antagonist | 0.026 0.022 CID_98840 0.026 0.023 CID_162171 | ||
| 0.014 | 0.008 | 0.014 | Cyclin D2 inhibitor | |||
| 0.051 | 0.045 | 0.069 | Argininosuccinate synthase inhibitor | 0.069 0.031 CID_98840 0.059 0.037 CID_162171 | CID_98840 | |
| 0.049 | 0.044 | 0.062 | Acyl-CoA dehydrogenase inhibitor | 0.062 0.032 CID_98840 0.054 0.039 CID_162171 | CID_98840 | |
| 0.058 | 0.053 | 0.058 | Dopamine D1 antagonist | |||
| 0.015 | 0.011 | 0.015 | CC chemokine 10 receptor antagonist | |||
| 0.052 | 0.048 | 0.052 | Alpha 1 adrenoreceptor agonist | |||
| 0.044 | 0.04 | 0.048 | Aldosterone antagonist | 0.048 0.031 CID_98840 0.043 0.041 CID_162171 | CID_98840 | |
| 0.016 | 0.012 | 0.016 | Nicotinic alpha4 receptor agonist | |||
| 0.034 | 0.031 | 0.034 | Bradykinin antagonist | |||
| 0.023 | 0.021 | 0.023 | Glutamate (mGluR1) agonist | |||
| 0.027 | 0.024 | 0.034 | Purinergic P2Y15 antagonist | 0.034 0.011 CID_98840 0.032 0.014 CID_162171 | CID_98840 | |
| 0.128 | 0.126 | 0.129 | Antipruritic | 0.129 0.124 CID_162171 | CID_162171 | |
| 0.038 | 0.036 | 0.038 | Plasmepsin II inhibitor | |||
| 0.036 | 0.035 | 0.046 | Vanilloid 3 antagonist | 0.038 0.028 CID_98840 0.046 0.012 CID_162171 | CID_162171 | |
| 0.009 | 0.008 | 0.009 | 2-Acylglycerol O-acyltransferase 2 inhibitor | |||
| 0.072 | 0.071 | 0.078 | Opioid kappa receptor antagonist | 0.078 0.061 CID_98840 0.073 0.07 CID_162171 | CID_98840 | |
| 0.06 | 0.059 | 0.06 | Orexin receptor antagonist | |||
| 0.047 | 0.046 | 0.047 | Cathepsin D inhibitor | |||
| 0.035 | 0.034 | 0.035 | Glutamate (mGluR8) agonist | |||
| 0.053 | 0.052 | 0.101 | Androgen agonist | 0.101 0.014 CID_98840 0.097 0.016 CID_162171 | CID_98840 | |
| 0.069 | 0.07 | 0.087 | Estrogen receptor alpha antagonist | 0.083 0.043 CID_98840 0.087 0.038 CID_162171 | CID_162171 | |
| 0.032 | 0.034 | 0.049 | Glutamate (mGluR3) antagonist | 0.049 0.013 CID_98840 0.045 0.015 CID_162171 | CID_98840 | |
| 0.063 | 0.067 | 0.107 | Na+ K+ transporting ATPase inhibitor | 0.107 0.025 CID_98840 0.104 0.028 CID_162171 | CID_98840 | |
| 0.057 | 0.061 | 0.059 | Interferon inducer | 0.059 0.056 CID_162171 | CID_162171 | |
| 0.082 | 0.088 | 0.133 | Lanosterol 14 alpha demethylase inhibitor | 0.133 0.02 CID_98840 0.121 0.029 CID_162171 | CID_98840 | |
| 0.031 | 0.038 | 0.041 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.039 0.022 CID_98840 0.041 0.02 CID_162171 | CID_162171 | |
| 0.062 | 0.071 | 0.075 | Glutamate dehydrogenase inhibitor | 0.075 0.05 CID_98840 0.068 0.06 CID_162171 | CID_98840 | |
| 0.012 | 0.022 | 0.017 | Thromboxane A2 agonist | 0.014 0.013 CID_98840 0.017 0.008 CID_162171 | CID_162171 | |
| 0.024 | 0.034 | 0.034 | Hedgehog signaling activator | 0.032 0.01 CID_98840 0.034 0.008 CID_162171 | CID_162171 | |
| 0.017 | 0.029 | 0.024 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.024 0.009 CID_98840 0.023 0.01 CID_162171 | CID_98840 | |
| 0.015 | 0.028 | 0.02 | Antibiotic Anthracycline-like | 0.02 0.01 CID_98840 0.02 0.012 CID_162171 | CID_162171 | |
| 0.121 | 0.134 | 0.145 | Melanin inhibitor | 0.139 0.098 CID_98840 0.145 0.089 CID_162171 | CID_162171 | |
| 0.022 | 0.039 | 0.029 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.029 0.013 CID_98840 0.028 0.015 CID_162171 | CID_98840 | |
| 0.023 | 0.043 | 0.031 | Fumarate hydratase inhibitor | 0.031 0.028 CID_98840 | CID_98840 | |
| 0.012 | 0.033 | 0.016 | Telomerase stimulant | 0.016 0.015 CID_162171 | CID_162171 | |
| 0.065 | 0.086 | 0.118 | Androgen antagonist | 0.118 0.034 CID_98840 0.116 0.036 CID_162171 | CID_98840 | |
| 0.022 | 0.045 | 0.028 | Cholesterol ester transfer protein antagonist | 0.028 0.027 CID_98840 | CID_98840 | |
| 0.075 | 0.101 | 0.088 | Protein kinase C zeta inhibitor | 0.088 0.069 CID_98840 | CID_98840 | |
| 0.088 | 0.115 | 0.117 | Microtubule formation inhibitor | 0.111 0.072 CID_98840 0.117 0.064 CID_162171 | CID_162171 | |
| 0.03 | 0.061 | 0.044 | Thymidine kinase inhibitor | 0.044 0.024 CID_98840 0.041 0.028 CID_162171 | CID_98840 | |
| 0.045 | 0.081 | 0.055 | Purinergic P2X1 antagonist | 0.055 0.052 CID_98840 | CID_98840 | |
| 0.059 | 0.096 | 0.072 | Keratolytic | 0.072 0.06 CID_98840 | CID_98840 | |
| 0.053 | 0.091 | 0.061 | Beta 2 adrenoreceptor agonist | 0.061 0.044 CID_98840 | CID_98840 | |
| 0.123 | 0.161 | 0.178 | ATPase inhibitor | 0.152 0.098 CID_98840 0.178 0.06 CID_162171 | CID_162171 | |
| 0.062 | 0.101 | 0.07 | GABA B receptor agonist | 0.07 0.068 CID_98840 | CID_98840 | |
| 0.058 | 0.098 | 0.072 | Adrenaline agonist | 0.072 0.069 CID_98840 | CID_98840 | |
| 0.025 | 0.066 | 0.056 | Opioid kappa receptor agonist | 0.056 0.02 CID_98840 | CID_98840 | |
| 0.078 | 0.122 | 0.115 | Alkylator | 0.11 0.078 CID_98840 0.115 0.073 CID_162171 | CID_162171 | |
| 0.077 | 0.122 | 0.117 | Mucolytic | 0.114 0.06 CID_98840 0.117 0.057 CID_162171 | CID_162171 | |
| 0.076 | 0.126 | 0.137 | Cholesterol synthesis inhibitor | 0.13 0.057 CID_98840 0.137 0.052 CID_162171 | CID_162171 | |
| 0.066 | 0.121 | 0.117 | Expectorant | 0.106 0.062 CID_98840 0.117 0.053 CID_162171 | CID_162171 | |
| 0.133 | 0.188 | 0.157 | Cyclic AMP phosphodiesterase inhibitor | 0.157 0.14 CID_98840 | CID_98840 | |
| 0.136 | 0.197 | 0.163 | DNA damaging | 0.163 0.154 CID_162171 | CID_162171 | |
| 0.023 | 0.084 | 0.038 | Tubulin agonist | 0.035 0.023 CID_98840 0.038 0.018 CID_162171 | CID_162171 | |
| 0.162 | 0.232 | 0.226 | Antithrombotic | 0.226 0.147 CID_98840 0.216 0.159 CID_162171 | CID_98840 | |
| 0.086 | 0.157 | 0.136 | Protein kinase stimulant | 0.136 0.079 CID_98840 0.136 0.079 CID_162171 | CID_162171 | |
| 0.118 | 0.19 | 0.224 | Immunostimulant | 0.191 0.126 CID_98840 0.224 0.107 CID_162171 | CID_162171 | |
| 0.092 | 0.177 | 0.122 | Hexokinase inhibitor | 0.122 0.115 CID_98840 | CID_98840 | |
| 0.109 | 0.199 | 0.162 | MAP kinase kinase 4 inhibitor | 0.156 0.051 CID_98840 0.162 0.042 CID_162171 | CID_162171 | |
| 0.062 | 0.152 | 0.098 | Bile acid receptor antagonist | 0.087 0.081 CID_98840 0.098 0.054 CID_162171 | CID_162171 | |
| 0.061 | 0.156 | 0.127 | Adenylate cyclase inhibitor | 0.12 0.067 CID_98840 0.127 0.062 CID_162171 | CID_162171 | |
| 0.061 | 0.167 | 0.132 | Amylase inhibitor | 0.122 0.08 CID_98840 0.132 0.074 CID_162171 | CID_162171 | |
| 0.012 | 0.12 | 0.034 | Farnesoid X receptor agonist | 0.034 0.031 CID_98840 0.033 0.032 CID_162171 | CID_98840 | |
| 0.085 | 0.2 | 0.139 | Heat shock protein 90 antagonist | 0.134 0.092 CID_98840 0.139 0.086 CID_162171 | CID_162171 | |
| 0.13 | 0.255 | 0.181 | Hypoxia-inducible factor 1 alpha inhibitor | 0.181 0.177 CID_162171 | CID_162171 | |
| 0.084 | 0.221 | 0.176 | Growth hormone agonist | 0.176 0.07 CID_162171 | CID_162171 | |
| 0.055 | 0.194 | 0.113 | AMP-activated protein kinase stimulant | 0.113 0.055 CID_98840 0.098 0.073 CID_162171 | CID_98840 | |
| 0.028 | 0.17 | 0.057 | Parathyroid hormone antagonist | 0.057 0.013 CID_98840 0.054 0.017 CID_162171 | CID_98840 | |
| 0.039 | 0.185 | 0.077 | AXL receptor tyrosine kinase inhibitor | 0.077 0.065 CID_162171 | CID_162171 | |
| 0.082 | 0.233 | 0.13 | Insulin secretagoues | 0.126 0.103 CID_98840 0.13 0.097 CID_162171 | CID_162171 | |
| 0.148 | 0.302 | 0.364 | Interleukin 2 agonist | 0.33 0.055 CID_98840 0.364 0.04 CID_162171 | CID_162171 | |
| 0.089 | 0.244 | 0.182 | Platelet antagonist | 0.182 0.115 CID_98840 0.169 0.127 CID_162171 | CID_98840 | |
| 0.112 | 0.28 | 0.225 | Transcription factor NF kappa B inhibitor | 0.19 0.179 CID_98840 0.225 0.146 CID_162171 | CID_162171 | |
| 0.125 | 0.294 | 0.406 | Immunosuppressant | 0.34 0.092 CID_98840 0.406 0.06 CID_162171 | CID_162171 | |
| 0.021 | 0.222 | 0.047 | Glucose-6-phosphate dehydrogenase inhibitor | 0.039 0.024 CID_98840 0.047 0.013 CID_162171 | CID_162171 | |
| 0.035 | 0.258 | 0.148 | Bronchodilator | 0.095 0.07 CID_98840 0.148 0.032 CID_162171 | CID_162171 | |
| 0.04 | 0.27 | 0.101 | Estrogen receptor beta antagonist | 0.101 0.062 CID_162171 | CID_162171 | |
| 0.016 | 0.246 | 0.042 | Acid-sensing ion channel blocker | 0.042 0.025 CID_98840 | CID_98840 | |
| 0.004 | 0.247 | 0.049 | RNA-directed RNA polymerase stimulant | 0.033 0.02 CID_98840 0.049 0.014 CID_162171 | CID_162171 | |
| 0.006 | 0.282 | 0.027 | 1,3-Beta-glucan synthase inhibitor | 0.027 0.025 CID_98840 | CID_98840 | |
| 0.039 | 0.317 | 0.115 | Neurotrophic factor | 0.115 0.103 CID_162171 | CID_162171 | |
| 0.045 | 0.325 | 0.115 | Estrogen antagonist | 0.106 0.085 CID_98840 0.115 0.065 CID_162171 | CID_162171 | |
| 0.051 | 0.43 | 0.12 | NOS3 expression enhancer | 0.12 0.115 CID_162171 | CID_162171 | |
| 0.029 | 0.43 | 0.055 | Lipocortins synthesis agonist | 0.055 0.049 CID_98840 0.055 0.048 CID_162171 | CID_162171 | |
| 0.062 | 0.483 | 0.175 | Lipocortins synthesis antagonist | 0.149 0.107 CID_98840 0.175 0.076 CID_162171 | CID_162171 | |
| 0.029 | 0.516 | 0.143 | Farnesoid X receptor antagonist | 0.143 0.061 CID_98840 0.14 0.066 CID_162171 | CID_98840 | |
| 0.017 | 0.507 | 0.093 | ATPase (Vacuolar H+) inhibitor | 0.086 0.065 CID_98840 0.093 0.051 CID_162171 | CID_162171 | |
| 0.081 | 0.593 | 0.259 | Peptidyltransferase inhibitor | 0.246 0.054 CID_98840 0.259 0.045 CID_162171 | CID_162171 | |
| 0.053 | 0.616 | 0.352 | Sodium/bile acid cotransporter inhibitor | 0.329 0.055 CID_98840 0.352 0.039 CID_162171 | CID_162171 | |
| 0.024 | 0.597 | 0.065 | MAP kinase kinase 8 inhibitor | 0.065 0.054 CID_98840 0.064 0.055 CID_162171 | CID_98840 | |
| 0.034 | 0.624 | 0.161 | Hepatoprotectant | 0.161 0.099 CID_162171 | CID_162171 | |
| 0.003 | 0.674 | 0.035 | HMG CoA reductase inhibitor | 0.033 0.027 CID_98840 0.035 0.022 CID_162171 | CID_162171 | |
| 0.023 | 0.726 | 0.155 | Interleukin 4 antagonist | 0.155 0.045 CID_98840 0.109 0.102 CID_162171 | CID_98840 | |
| 0.008 | 0.761 | 0.161 | Hypolipemic | 0.161 0.127 CID_98840 | CID_98840 | |
| 0.013 | 0.839 | 0.238 | Cyclophilin D inhibitor | 0.238 0.226 CID_98840 | CID_98840 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |